You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity

 

Online download statistics by month:

Online download statistics by month: January 2024 to September 2025

AbstractFullPdf
Jan 2024808223
Feb 2024681703282
Mar 2024238238154
Apr 2024838458
May 2024798147
Jun 202410010256
Jul 202410010055
Aug 2024535228
Sep 2024696943
Oct 2024686842
Nov 2024757634
Dec 2024818355
Jan 2025697042
Feb 202519419436
Mar 2025585928
Apr 2025909456
May 2025575948
Jun 2025404033
Jul 2025110
Sep 2025210
Total221822561120